Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis C

Free Subscription Articles published in Transplantation Retrieve available abstracts of 18 articles: HTML format

Single Articles

November 2022
1. MYERS B, Bekki Y, Kozato A, Crismale JF, et al
   DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
   Transplantation. 2022 Nov 7. pii: 00007890-990000000-00240.
   PubMed     Abstract available
   
   
   October 2022
2. WOOLLEY AE, Gandhi AR, Jones ML, Kim JJ, et al
   The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.
   Transplantation. 2022 Oct 27. doi: 10.1097/TP.0000000000004378.
   PubMed     Abstract available
   
   
   May 2022
3. SIBULESKY L, Leca N, Limaye AP, Ramasamy B, et al
   Survival Benefit in Older Patients Transplanted With Viremic Hepatitis C Positive Kidneys When Compared With High KDPI Kidneys.
   Transplantation. 2022 May 27. pii: 00007890-990000000-00059.
   PubMed     Abstract available
   
   
   April 2022
4. BEKKI Y, Crismale JF, Myers B, Schiano TD, et al
   Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the US: An Analysis of the OPTN/UNOS Database.
   Transplantation. 2022 Apr 6. pii: 00007890-990000000-00025.
   PubMed     Abstract available
   
   
   
5. GUPTA G, Devarakonda T, Sharma A, Miles M, et al
   Ultrashort Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
   Transplantation. 2022;106:e234-e235.
   PubMed    
   
   
   February 2022
6. COTTER TG, Charlton M
   The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
   Transplantation. 2022;106:e166.
   PubMed    
   
   
   
7. BEKKI Y, Myers B
   Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.
   Transplantation. 2022;106:e165.
   PubMed    
   
   
   
8. WALLER KMJ, De La Mata NL, Rosales BM, Hedley JA, et al
   Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
   Transplantation. 2022;106:348-357.
   PubMed     Abstract available
   
   
   July 2021
9. RICHTER BI, Parent B, Lonze BE
   The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV Naive Patients.
   Transplantation. 2021 Jul 22. pii: 00007890-900000000-95189.
   PubMed    
   
   
   May 2021
10. MUTHUKUMAR T, Akat KM, Yang H, Schwartz JE, et al
    Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.
    Transplantation. 2021 May 11. pii: 00007890-900000000-95253.
    PubMed     Abstract available
    
    
    February 2021
11. CALABRESE DR
    Ribavirin to the Rescue: Natural Killer Cell Function After Hepatitis C Virus Treatment in Liver Transplant Recipients.
    Transplantation. 2021 Feb 12. pii: 00007890-900000000-95359.
    PubMed    
    
    
    
12. YOELI D, Choudhury RA, Moore HB, Sauaia A, et al
    Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Re-Examining the Disparity in the Modern Era of Direct Acting Antiviral Agents.
    Transplantation. 2021 Feb 11. pii: 00007890-900000000-95364.
    PubMed     Abstract available
    
    
    
13. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
    Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
    PubMed     Abstract available
    
    
    January 2021
14. FUJISAKI T, Mikami T, Kuno T, Moss N, et al
    Effect of Hepatitis C Virus Infection on Heart Transplants in the Current Era.
    Transplantation. 2021 Jan 25. pii: 00007890-900000000-95404.
    PubMed     Abstract available
    
    
    December 2020
15. ADENUGBA A, Hornung M, Weigand K, Peschel G, et al
    Ribavirin Improves NK Cell IFNgamma Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95432.
    PubMed     Abstract available
    
    
    October 2020
16. NGUYEN T, Sise ME, Delgado C, Williams W, et al
    Race, Education, and Gender Disparities in Transplantation of Kidneys from Hepatitis C Viremic Donors.
    Transplantation. 2020 Oct 29. doi: 10.1097/TP.0000000000003511.
    PubMed     Abstract available
    
    
    January 2020
17. GORGEN A, Galvin Z, Huang AC, Vinaixa C, et al
    The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study.
    Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003115.
    PubMed     Abstract available
    
    
    August 2019
18. WEEKS SR, Luo X, Haugen CE, Ottmann SE, et al
    Delayed graft function in simultaneous liver kidney transplantation.
    Transplantation. 2019 Aug 8. doi: 10.1097/TP.0000000000002908.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: